# SENDERO BIOTECHNOLOGY, INC. — Form D

SENDERO BIOTECHNOLOGY, INC. of ROCHESTER, MI, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-28. The offering totals $7.3M, of which $7.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-04-28
- Form: D
- Accession: 0001975410-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $7.3M
- Investors: 2
- Date of first sale: 2023-04-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480333

## Issuer

- Name: SENDERO BIOTECHNOLOGY, INC.
- CIK: 0001975410
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 303 E. THIRD STREET, ROCHESTER, MI, 48307
- Phone: 703-405-9113

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Badley | Director | Rochester, MI |
| Joshua Barer | Director | Rochester, MI |
| Michael Cola | Director | Toronto, A6 |
| Gloria Olivier | Director | Rochester, MI |
| Michael Cola | Executive Officer | Toronto, A6 |

## More

- [CIK 1975410 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1975410&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001975410-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.